Physician profile
Michael Jason Beebe
NPI 1497071146
$625,586.37
in general payments reported to CMS, 2019-2025
34 companies · $211K in 2025
The $211K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $27K · 2021: $56K · 2022: $104K · 2023: $105K · 2024: $91K · 2025: $211K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $132K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $126K · Royalty Or License: $111K · Travel and Lodging: $27K · Food and Beverage: $7,975 · Debt Forgiveness: $2,250 · Education: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $131,911.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $126,237.51 |
| Royalty Or License | $110,783.84 |
| Travel and Lodging | $26,732.69 |
| Food and Beverage | $7,975.18 |
| Debt Forgiveness | $2,250.00 |
| Education | $238.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $352,142.39 | 2019-2025 | Pangea, Axsos, Pro |
| Smith+Nephew, INC. | $238,900.38 | 2019-2025 | Evos, Trigen, Evos Mini |
| Advanced Orthopaedic Solutions, INC. | $11,626.17 | 2019-2020 | |
| Synthes Gmbh | $8,066.66 | 2019-2020 | |
| Arthrex, INC. | $3,827.35 | 2021 | |
| Acera Surgical, INC. | $2,853.80 | 2022-2025 | Restrata Wound Matrix |
| Medartis INC. | $2,180.00 | 2022 | |
| Distalmotion US | $2,000.00 | 2024 | Dexter L6 Robot |
| Biotissue Holdings INC. | $802.78 | 2022-2025 | |
| Gentleman Orthopedic Solutions | $774.53 | 2020-2021 | |
| Depuy Synthes Sales INC. | $478.95 | 2019-2022 | |
| Polynovo North America LLC | $308.97 | 2022-2023 | |
| Arteriocyte Medical Systems, INC. | $193.52 | 2020 | |
| Bioventus LLC | $192.73 | 2019-2022 | |
| Abyrx, INC | $191.31 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $122.32 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kci USA, INC. | $110.87 | 2019-2021 | |
| Trimed, INC. | $98.63 | 2019 | |
| Skeletal Dynamics INC | $74.72 | 2021 | |
| Davol INC. | $68.51 | 2022 | |
| Dilon Technologies, INC. | $64.75 | 2025 | Hemoblast Bellows |
| Bone Support INC. | $64.01 | 2022 | |
| Aroa Biosurgery Incorporated | $61.75 | 2025 | |
| Sanara Medtech INC. | $56.95 | 2021 | |
| Solventum Corporation | $47.97 | 2025 | V.A.C.Ulta, Prevena, V.A.C. Veraflo |
| Depuy Synthes Products, INC. | $46.92 | 2022 | |
| Zimmer Biomet Holdings, INC. | $40.15 | 2019 | |
| Si-Bone, INC. | $36.26 | 2025 | |
| Misonix INC | $31.59 | 2019 | |
| Orthofix Medical, INC. | $28.15 | 2019 | |
| Acumed LLC | $26.06 | 2019 | |
| Flower Orthopedics Coporation | $23.20 | 2023 | |
| Convatec INC. | $22.91 | 2019 | |
| Integra Lifesciences Corporation | $21.11 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Beebe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.